Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine

Neurological Sciences

Volumn 27, Issue SUPPL. 2, 2006, Pages

  Welch, K Michael A ^a   Brandes, J L ^b   Berman, N E J ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Nashville Neuroscience Group   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Menstrual migraine; Migraine; Oestrogen; Ovarian steroids

Indexed keywords

ESTROGEN; MITOGENIC AGENT; NEUROTRANSMITTER; PEPTIDE; SEX HORMONE;

BRAIN CORTEX; CELL MEMBRANE; DISABILITY; DOWN REGULATION; ESTROGEN ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; MENSTRUAL MIGRAINE; MENSTRUATION; MIGRAINE; MOLECULAR DYNAMICS; NERVE CELL EXCITABILITY; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; UPREGULATION; DRUG EFFECT; DYSMENORRHEA; FEMALE; NERVE CELL;

DYSMENORRHEA; ESTROGENS; FEMALE; HUMANS; MIGRAINE DISORDERS; NEURONS;

EID: 33746319907     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0599-6     Document Type: Review

References (19)

1. Welch KMA, Darnley D, Simkins RT (1984) The role of estrogen in migraine: A review and hypothesis. Cephalalgia 4:227-236
2. Brandes JL (2006) The influence of estrogen on migraine: Current understanding and future directions. JAMA (in press)
3. Somerville BW (1975) Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 25:239-244
4. Somerville BW (1975) Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 3:245-250
5. Nagel-Leiby S,Welch KM, Grunfeld S, D'Andrea G (1990) Ovarian steroid levels in migraine with and without aura. Cephalalgia 10:147-152
6. MacGregor A (1999) Estrogen replacement and migraine aura. Headache 39:674-678
7. Nagel-Leiby S, Welch KM, D'Andrea G, Grunfeld S, Brown E (1990) Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 10:317-329
8. Welch KMA, D'Andrea G, Tepley N, Barkeley GL, Ramadan NM (1990) The concept of migraine as a state of central neuronal hyper excitability. Headache 8:817-828
9. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340-352
10. Goadsby PJ, Edvinsson L, Ekman R (1984) Release of vasoactive peptides in vascular head pain. Ann Neurol 16:157-168
11. Abounader R, Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Quirion R, Hamel E (1999) Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture. J Cereb Blood Flow Metab 19:155-163
12. Yu XJ, Moskowitz MA (1996) Neuropeptide Y Y2 receptormediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br J Pharmacol 119:229-232
13. Kerr BJ, Thompson SW, Wynick D, McMahon SB (2000) Endogenous galanin is required for the full expression of central sensitization following peripheral nerve injury. Neuroreport 12:3331-3334
14. Weisenfeldt-Hallin Z et al (1992) Galanin-mediated control of pain: enhanced role after peripheral nerve injury. Proc Natl Acad Sci USA 89:3334-3337
15. Puri V et al (2005) Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides 39:409-417
16. Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L (2002) Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology 58:1227-1233
17. Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNLA4. Cell 87:543-552
18. Bowyer SM, Aurora SK, Moran JE, Tepley N, Welch KMA (2001) Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 50:582-587
19. Choudhuri R, Cui L, Yong C, Bowyer S, Klein RM, Welch KM, Berman NE (2002) Cortical spreading depression and gene regulation: Relevance to migraine. Ann Neurol 51:499-506